U.S. Stem Cell Management
Management criteria checks 3/4
U.S. Stem Cell's CEO is Mike Tomas, appointed in Jun 2010, has a tenure of 13.92 years. directly owns 1.51% of the company’s shares, worth $10.00. The average tenure of the management team and the board of directors is 11 years and 15.6 years respectively.
Key information
Mike Tomas
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 13.9yrs |
| CEO ownership | 1.5% |
| Management average tenure | 11yrs |
| Board average tenure | 15.6yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2022 | n/a | n/a | -US$3m |
| Sep 30 2022 | n/a | n/a | -US$3m |
| Jun 30 2022 | n/a | n/a | -US$3m |
| Mar 31 2022 | n/a | n/a | -US$3m |
| Dec 31 2021 | US$327k | US$327k | -US$3m |
| Sep 30 2021 | n/a | n/a | -US$3m |
| Jun 30 2021 | n/a | n/a | -US$4m |
| Mar 31 2021 | n/a | n/a | -US$3m |
| Dec 31 2020 | US$630k | US$130k | -US$3m |
| Sep 30 2020 | n/a | n/a | -US$3m |
| Jun 30 2020 | n/a | n/a | -US$3m |
| Mar 31 2020 | n/a | n/a | -US$4m |
| Dec 31 2019 | US$2m | US$881k | -US$4m |
| Sep 30 2019 | n/a | n/a | -US$4m |
| Jun 30 2019 | n/a | n/a | -US$2m |
| Mar 31 2019 | n/a | n/a | -US$3m |
| Dec 31 2018 | US$3m | US$1m | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$1m |
| Jun 30 2018 | n/a | n/a | -US$2m |
| Mar 31 2018 | n/a | n/a | -US$1m |
| Dec 31 2017 | US$3m | US$1m | -US$3m |
Compensation vs Market: Insufficient data to establish whether Mike's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.
CEO
Mike Tomas (57 yo)
13.9yrs
Tenure
Mr. Michael Tomas, also known as Mike, has been the Chief Executive Officer and President of U.S. Stem Cell, Inc. since June 18, 2010. Mr. Tomas serves as the Vice President of Corporate Affairs of Pharmed...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President | 13.9yrs | no data | 1.51% $ 10.0 | |
| Senior Compliance Officer | 10.7yrs | no data | no data | |
| Senior Vice President of U.S. & International Sales | 5.7yrs | no data | no data | |
| Corporate Controller | 11yrs | no data | no data | |
| Medical Director & Member of Scientific Advisory Board | 19.4yrs | no data | no data |
11.0yrs
Average Tenure
Experienced Management: USRM's management team is seasoned and experienced (11 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President | 13.9yrs | no data | 1.51% $ 10.0 | |
| Medical Director & Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Chairman | 6.4yrs | no data | 0.080% $ 0.5 | |
| Chairman Emeritus | 20.9yrs | no data | 0.0096% $ 0.06 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 17.3yrs | no data | no data |
15.6yrs
Average Tenure
75yo
Average Age
Experienced Board: USRM's board of directors are seasoned and experienced ( 15.6 years average tenure).